ADARx Pharmaceuticals IPO Greenshoe Fully Exercised
ADARx Pharmaceuticals' initial public offering has seen its underwriters fully exercise the option to purchase an additional 3,937,500 shares at $17 per share. This brings the total number of IPO shares to 30,187,500, generating gross proceeds of approximately $513.2 million. An additional $89.3 million was raised thro